Displaying results 1 - 7 of 7
Regional integration offers path to resilient future, UNCTAD15 hears
7 Oct 2021
As multilateralism fails to provide many developing countries with the tools they need to respond to the COVID-19 pandemic, regional cooperation offers hope to building back better.
Ten actions to boost low and middle-income countries’ productive capacity for medicines
27 May 2020
Written by James Zhan, Director, Division on Investment and Enterprise, and Christoph Spennemann, Chief, Intellectual Property Unit, UNCTAD
COVID-19 heightens need for pharmaceutical production in poor countries
27 May 2020
UNCTAD and the WHO have teamed up to respond to the urgent call to boost local production of essential medicines in developing countries.
UN to boost health tech production for COVID-19
14 May 2020
UN agencies launched the Tech Access Partnership in a joint effort to scale up local production of life-saving health technologies for COVID-19.
Fostering investment in the development of new antibacterial treatments
20 Nov 2018
An event on fostering investment in the development of new antibacterial treatments was held on 23 October 2018 at the Palais des Nations, Geneva during the World Investment Forum (WIF).
East African pharma companies missing out on fast growing $5 billion opportunity
4 Nov 2016
The $5 billion East African pharmaceutical market is expected to grow by more than 12% per year for the next five years, as lifestyle changes in the region lead to higher rates of non-communicable diseases such as diabetes.
Investments needed to scale up access to essential medicines
17 Oct 2014
Improving access to medicines can be enhanced by local production of pharmaceuticals in developing countries. But to do so, both the public and the private sector need to work together, said James Zhan, Director of UNCTAD's Division on Investment and Enterprise at the World Investment Forum's Policy Debate on Public Health.